BurgherGray represented the Latin American biopharmaceutical company, Biopas in a cross-border financing transaction that was covered by the Global Legal Chronical.
Read the article “Darby’s $45 Million Investment in Pharma Consulting Group”.
BurgherGray Leads Biopas in Latin American Cross-Border Leveraged Financing Transaction
Share
Related Posts
Jessica Kopas at NAMWOLF: Biometrics in Litigation
October 5, 2026
The Kalshi Litigation: The Ninth Circuit Rules
September 28, 2026